Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy ; volume:13 ; number:1 ; day:3 ; month:4 ; year:2024 ; pages:1-34 ; date:12.2024
Experimental hematology & oncology ; 13, Heft 1 (3.4.2024), 1-34, 12.2024
- Urheber
-
Shao, Weihuan
Yao, Yiran
Yang, Ludi
Li, Xiaoran
Ge, Tongxin
Zheng, Yue
Zhu, Qiuyi
Ge, Shengfang
Gu, Xiang
Jia, Renbing
Song, Xin
Zhuang, Ai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-024-00504-8
- URN
-
urn:nbn:de:101:1-2406190935229.300319991259
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shao, Weihuan
- Yao, Yiran
- Yang, Ludi
- Li, Xiaoran
- Ge, Tongxin
- Zheng, Yue
- Zhu, Qiuyi
- Ge, Shengfang
- Gu, Xiang
- Jia, Renbing
- Song, Xin
- Zhuang, Ai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy against ovarian cancer
Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy
TCR-like antibodies in cancer immunotherapy
TCR diversity – a universal cancer immunotherapy biomarker?
Generation of dual T cell receptor (TCR) T cells by TCR gene transfer for adoptive T cell therapy
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy via CD4+ versus CD8+ T cells
Adoptive immunotherapy for treatment of chronic hepatitis B
TCR engineered T cells for solid tumor immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy